Catherine Lai, MD, MPH | Aplastic Anemia & MDS International Foundation

Catherine Lai, MD, MPH

Position / Title: 
Director of Leukemia
Institution: 
Washington Med Star Georgetown University Hospital
Primary Disease Area of Focus: 
  • acute myeloid leukemia (AML)
  • myelodysplastic syndromes (MDS)

Catherine Lai, MD, MPH, is the director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center. Board certified in hematology, medical oncology, and internal medicine, Dr. Lai specializes in detecting, monitoring, and treating acute leukemia in adults. Previously at the National Institutes of Health (NIH), she focused on clinical trials in acute leukemias. Under Dr. Lai’s leadership, the leukemia program offers acute leukemia patients advanced and highly specialized care, including clinical trials with immunotherapy. Dr. Lai’s clinical expertise complements a multidisciplinary team of specialists dedicated to MedStar Georgetown’s Stem Cell Transplant and Cellular Immunotherapy Program, which is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and offers treatment with stem cell transplants (autologous and allogeneic) and CAR-T cell therapy. Dr. Lai’s research focuses on novel therapeutics, designing and conducting clinical trials, and health outcomes for leukemia patients.

Practice Location: 
Washington Med Star Georgetown University Hospital
Washington , DC 20007
US
Physician Status: 
  • accepting new patients